Personalis: A Growth Inflection Is Imminent, Hold [Seeking Alpha]
Personalis, Inc. (PSNL)
Last personalis, inc. earnings: 3/25 04:01 pm
Check Earnings Report
Company Research
Source: Seeking Alpha
While the NeXT Personal test appears to offer superior performance, competition is likely to increase significantly over the next few years as competitors introduce similar capabilities. Personalis' market capitalization is still modest relative to the size of the MRD opportunity, which could see the stock continue to move higher as Medicare coverage expands. Q4 2025 results are still likely to be soft, though, and investor expectations are now fairly elevated. Jeng_Niamwhan/iStock via Getty Images Personalis ( PSNL ) is a liquid biopsy company that is initially targeting the MRD and drug research markets. While competition in these markets is fierce, Personalis is differentiated by its whole genome sequencing approach, which should benefit from This article was written by Analyst's Disclosure: I/we have a beneficial long position in the shares of GH either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinion
Show less
Read more
Impact Snapshot
Event Time:
PSNL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PSNL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PSNL alerts
High impacting Personalis, Inc. news events
Weekly update
A roundup of the hottest topics
PSNL
News
- Personalis (NASDAQ:PSNL) was given a new $11.00 price target on by analysts at Morgan Stanley.MarketBeat
- Personalis to Participate in the Piper Sandler 37th Annual Healthcare ConferenceBusiness Wire
- Personalis (NASDAQ:PSNL) had its price target raised by analysts at Morgan Stanley from $5.00 to $9.00. They now have an "equal weight" rating on the stock.MarketBeat
- Personalis (NASDAQ:PSNL) had its price target raised by analysts at Guggenheim from $6.00 to $12.00. They now have a "buy" rating on the stock.MarketBeat
- Personalis (NASDAQ:PSNL) had its price target raised by analysts at BTIG Research from $11.00 to $12.00. They now have a "buy" rating on the stock.MarketBeat
PSNL
Earnings
- 11/4/25 - Beat
PSNL
Sec Filings
- 11/28/25 - Form 8-K
- 11/28/25 - Form 424B5
- 11/28/25 - Form 4
- PSNL's page on the SEC website